van Gerven NM, de Boer YS, Mulder CJ, van Nieuwkerk CM, Bouma G. Autoimmune hepatitis. World J Gastroenterol. 2016;22:4651–61.

Article  PubMed  PubMed Central  Google Scholar 

Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, Chapman RW, Cooksley WGE, Czaja AJ, Desmet VJ, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999;31:929–38.

Article  CAS  PubMed  Google Scholar 

Hennes EM, Zeniya M, Czaja AJ, Pares A, Dalekos GN, Krawitt EL, Bittencourt PL, Porta G, Boberg KM, Hofer H, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology. 2008;48:169–76.

Article  PubMed  Google Scholar 

Lohse AW, Chazouillères O, Dalekos G, Drenth JP, Heneghan M, Hofer H, Lammert F, Lenzi M. EASL Clinical Practise Guideline Autoimmune Hepatitis. J Hepatol. 2015;63:971–1004.

Article  Google Scholar 

Biewenga M, Verhelst X, Baven-Pronk M, Putter H, van den Berg A, Colle I, Schouten J, Sermon F, Van Steenkiste C, van Vlierberghe H, et al. Aminotransferases during treatment predict long-term survival in patients with autoimmune hepatitis type 1: a landmark analysis. Clin Gastroenterol Hepatol; 2021.

Pape S, Snijders R, Gevers TJG, Chazouilleres O, Dalekos GN, Hirschfield GM, Lenzi M, Trauner M, Manns MP, Vierling JM, et al. Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group. J Hepatol. 2022;76:841–9.

Article  PubMed  Google Scholar 

van Gerven NM, Verwer BJ, Witte BI, van Hoek B, Coenraad MJ, van Erpecum KJ, Beuers U, van Buuren HR, de Man RA, Drenth JP, et al. Relapse is almost universal after withdrawal of immunosuppressive medication in patients with autoimmune hepatitis in remission. J Hepatol. 2013;58:141–7.

Article  PubMed  Google Scholar 

Rudd PM, Elliott T, Cresswell P, Wilson IA, Dwek RA. Glycosylation and the immune system. Science. 2001;291:2370–6.

Article  CAS  PubMed  Google Scholar 

Varki A. Biological roles of glycans. Glycobiology. 2017;27:3–49.

Article  CAS  PubMed  Google Scholar 

Callewaert N, Van Vlierberghe H, Van Hecke A, Laroy W, Delanghe J, Contreras R. Noninvasive diagnosis of liver cirrhosis using DNA sequencer-based total serum protein glycomics. Nat Med. 2004;10:429–34.

Article  CAS  PubMed  Google Scholar 

Verhelst X, Vanderschaeghe D, Castera L, Raes T, Geerts A, Francoz C, Colman R, Durand F, Callewaert N, Van Vlierberghe H. A glycomics-based test predicts the development of Hepatocellular Carcinoma in cirrhosis. Clin Cancer Res. 2017;23:2750–8.

Article  CAS  PubMed  Google Scholar 

Ramachandran P, Xu G, Huang HH, Rice R, Zhou B, Lindpaintner K, Serie D. Serum glycoprotein markers in nonalcoholic steatohepatitis and Hepatocellular Carcinoma. J Proteome Res. 2022;21:1083–94.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Somers N, Vandekerckhove E, Geerts A, Degroote H, Lefere S, Devisscher L, Meuris L, Callewaert N, Van Vlierberghe H, Verhelst X. Glycomics-based serum markers as reliable tool for assessment of viral response after treatment with direct-acting antiviral drugs in hepatitis C virus infection. Acta Clin Belg. 2023;78:96–102.

Article  CAS  PubMed  Google Scholar 

Vanderschaeghe D, Laroy W, Sablon E, Halfon P, Van Hecke A, Delanghe J, Callewaert N. GlycoFibroTest is a highly performant liver fibrosis biomarker derived from DNA sequencer-based serum protein glycomics. Mol Cell Proteom. 2009;8:986–94.

Article  CAS  Google Scholar 

Scott DA, Wang M, Grauzam S, Pippin S, Black A, Angel PM, Drake RR, Castellino S, Kono Y, Rockey DC, Mehta AS. GlycoFibroTyper: a Novel Method for the glycan analysis of IgG and the development of a Biomarker signature of liver fibrosis. Front Immunol. 2022;13:797460.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Clerc F, Novokmet M, Dotz V, Reiding KR, de Haan N, Kammeijer GSM, Dalebout H, Bladergroen MR, Vukovic F, Rapp E, et al. Plasma N-Glycan signatures are Associated with features of Inflammatory Bowel diseases. Gastroenterology. 2018;155:829–43.

Article  CAS  PubMed  Google Scholar 

Dotz V, Lemmers RFH, Reiding KR, Hipgrave Ederveen AL, Lieverse AG, Mulder MT, Sijbrands EJG, Wuhrer M, van Hoek M. Plasma protein N-glycan signatures of type 2 diabetes. Biochim et Biophys Acta (BBA) - Gen Subj. 2018;1862:2613–22.

Article  CAS  Google Scholar 

Verhelst X, Dias AM, Colombel JF, Vermeire S, Van Vlierberghe H, Callewaert N, Pinho SS. Protein glycosylation as a diagnostic and prognostic marker of Chronic Inflammatory Gastrointestinal and Liver diseases. Gastroenterology. 2020;158:95–110.

Article  CAS  PubMed  Google Scholar 

Blomme B, Van Steenkiste C, Callewaert N, Van Vlierberghe H. Alteration of protein glycosylation in liver diseases. J Hepatol. 2009;50:592–603.

Article  CAS  PubMed  Google Scholar 

Subedi GP, Barb AW. The structural role of antibody N-Glycosylation in receptor interactions. Structure. 2015;23:1573–83.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Malhotra R, Wormald MR, Rudd PM, Fischer PB, Dwek RA, Sim RB. Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein. Nat Med. 1995;1:237–43.

Article  CAS  PubMed  Google Scholar 

Šimurina M, de Haan N, Vučković F, Kennedy NA, Štambuk J, Falck D, Trbojević-Akmačić I, Clerc F, Razdorov G, Khon A, et al. Glycosylation of Immunoglobulin G Associates with Clinical features of Inflammatory Bowel diseases. Gastroenterology. 2018;154:1320–e13331310.

Article  PubMed  Google Scholar 

Plomp R, Ruhaak LR, Uh HW, Reiding KR, Selman M, Houwing-Duistermaat JJ, Slagboom PE, Beekman M, Wuhrer M. Subclass-specific IgG glycosylation is associated with markers of inflammation and metabolic health. Sci Rep. 2017;7:12325.

Article  PubMed  PubMed Central  Google Scholar 

de Haan N, Reiding KR, Driessen G, van der Burg M, Wuhrer M. Changes in healthy human IgG Fc-Glycosylation after birth and during early childhood. J Proteome Res. 2016;15:1853–61.

Article  PubMed  Google Scholar 

Knezevic A, Gornik O, Polasek O, Pucic M, Redzic I, Novokmet M, Rudd PM, Wright AF, Campbell H, Rudan I, Lauc G. Effects of aging, body mass index, plasma lipid profiles, and smoking on human plasma N-glycans. Glycobiology. 2010;20:959–69.

Article  CAS  PubMed  Google Scholar 

Vanhooren V, Desmyter L, Liu XE, Cardelli M, Franceschi C, Federico A, Libert C, Laroy W, Dewaele S, Contreras R, Chen C. N-glycomic changes in serum proteins during human aging. Rejuvenation Res. 2007;10:521–a531.

Article  PubMed  Google Scholar 

Pongracz T, Nouta J, Wang W, van Meijgaarden KE, Linty F, Vidarsson G, Joosten SA, Ottenhoff THM, Hokke CH, de Vries JJC et al. Immunoglobulin G1 Fc glycosylation as an early hallmark of severe COVID-19. eBioMedicine: 2022, 78:103957.

Pongracz T, Vidarsson G, Wuhrer M. Antibody glycosylation in COVID-19. Glycoconj J 2022.

Vreeker GCM, Nicolardi S, Bladergroen MR, van der Plas CJ, Mesker WE, Tollenaar RAEM, van der Burgt YEM, Wuhrer M. Automated plasma glycomics with linkage-specific sialic acid esterification and Ultrahigh Resolution MS. Anal Chem. 2018;90:11955–61.

Article  CAS  PubMed  PubMed Central  Google Scholar 

European Association for the Study of the Liver. Electronic address eee, European Association for the study of the L: EASL Clinical Practice guidelines on sclerosing cholangitis. J Hepatol. 2022;77:761–806.

Article  Google Scholar 

European Association for the Study of the Liver. Electronic address eee, European Association for the study of the L: EASL Clinical Practice guidelines: the diagnosis and management of patients with primary biliary cholangitis. J Hepatol. 2017;67:145–72.

Article  Google Scholar 

European Association for the Study of the L. European Association for the Study of D, European Association for the study of O: EASL-EASD-EASO Clinical Practice guidelines for the management of non-alcoholic fatty liver disease. J Hepatol. 2016;64:1388–402.

Article  Google Scholar 

Falck D, Jansen BC, de Haan N, Wuhrer M. High-throughput analysis of IgG fc glycopeptides by LC-MS. Methods Mol Biol. 2017;1503:31–47.

Article  CAS  PubMed  Google Scholar 

de Haan N, Boeddha NP, Ekinci E, Reiding KR, Emonts M, Hazelzet JA, Wuhrer M, Driessen GJ. Differences in IgG Fc Glycosylation Are Associated with Outcome of Pediatric Meningococcal Sepsis. mBio 2018, 9.

Clerc F, Reiding KR, Jansen BC, Kammeijer GS, Bondt A, Wuhrer M. Human plasma protein N-glycosylation. Glycoconj J. 2016;33:309–43.

Article  CAS  PubMed  Google Scholar 

Wuhrer M, Stam JC, van de Geijn FE, Koeleman CA, Verrips CT, Dolhain RJ, Hokke CH, Deelder AM. Glycosylation profiling of immunoglobulin G (IgG) subclasses from human serum. Proteomics. 2007;7:4070–81.

Article  CAS  PubMed  Google Scholar 

Takakura D, Harazono A, Hashii N, Kawasaki N. Selective glycopeptide profiling by acetone enrichment and LC/MS. J Proteom. 2014;101:17–30.

Article  CAS  Google Scholar 

Imre T, Schlosser G, Pocsfalvi G, Siciliano R, Molnar-Szollosi E, Kremmer T, Malorni A, Vekey K. Glycosylation site analysis of human alpha-1-acid glycoprotein (AGP) by capillary liquid chromatography-electrospray mass spectrometry. J Mass Spectrom. 2005;40:1472–83.

Article  CAS  PubMed  Google Scholar 

Treuheit MJ, Costello CE, Halsall HB. Analysis of the five glycosylation sites of human alpha 1-acid glycoprotein. Biochem J. 1992;283(Pt 1):105–12.

Article  CAS  PubMed  PubMed Central  Google Scholar